Results 1 to 10 of about 11,226 (207)

Resolving the Interference of Anti-CD38 Antibodies on Blood Compatibility Assays Using CD38 "Baitbodies" Approach. [PDF]

J Immunol Res
Gnann DC, Steinke S, Garritsen HSP, Hust M.   +3 more
europepmc   +1 more source

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma. [PDF]

J Adv Pract Oncol
Davis M.
europepmc   +1 more source

Patient with AL amyloidosis with recurrent syncope as the first symptom: case report and literature review. [PDF]

Front Oncol
Hu L, Luo L, Yao N, Mi J, Zhang Y, Sun M, Wang H, Xu Y, Wang W, Hu J, Lu H.   +10 more
europepmc   +1 more source

Unexpected impact on immunohematological diagnostics from transplantation of autologous stem cell preparations containing daratumumab. [PDF]

Haematologica
Luckner K, Wortmann F, Glessing P, Görg S, Juhl D.   +4 more
europepmc   +1 more source

Safety and efficacy of daratumumab in immune thrombocytopenia. [PDF]

Blood Adv
Tsykunova G, Holme PA, Tran HTT, Frederiksen H, Tjønnfjord E, Munthe LA, Drivet E, Kared H, Sørvoll IH, Ahlen MT, Mahévas M, Michel M, Bussel J, Kuter DJ, Anderson Tvedt TH, Ghanima W.   +15 more
europepmc   +1 more source

Complex Chromothripsis-like Features in Plasma Cell Myeloma: A Case Report and Review of the Literature. [PDF]

Diagnostics (Basel)
Oentoro J, Yu S, Murgas KA, Rocha J, Ahmed T, Tirado CA.   +5 more
europepmc   +1 more source

Case report: anti-GAD65 antibody-associated epilepsy as the primary manifestation of chronic graft-versus-host disease. [PDF]

Ann Hematol
Yang S, Gu P, Tian J, Tang X, Xue Q.
europepmc   +1 more source

Daratumumab

Reactions Weekly
  +14 more sources